Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Cognitive impairment associated with atrial fibrillation: a meta-analysis.

Kalantarian S, Stern TA, Mansour M, Ruskin JN.

Ann Intern Med. 2013 Mar 5;158(5 Pt 1):338-46. doi: 10.7326/0003-4819-158-5-201303050-00007. Review.

2.

Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review.

Udompanich S, Lip GY, Apostolakis S, Lane DA.

QJM. 2013 Sep;106(9):795-802. doi: 10.1093/qjmed/hct129. Epub 2013 Jun 3. Review.

PMID:
23737509
3.

Association between atrial fibrillation and silent cerebral infarctions: a systematic review and meta-analysis.

Kalantarian S, Ay H, Gollub RL, Lee H, Retzepi K, Mansour M, Ruskin JN.

Ann Intern Med. 2014 Nov 4;161(9):650-8. doi: 10.7326/M14-0538. Review.

PMID:
25364886
4.

Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.

Mead GE, Hsieh CF, Lee R, Kutlubaev MA, Claxton A, Hankey GJ, Hackett ML.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD009286. doi: 10.1002/14651858.CD009286.pub2. Review.

PMID:
23152272
5.

Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation.

Bruins Slot KM, Berge E.

Cochrane Database Syst Rev. 2013 Aug 8;(8):CD008980. doi: 10.1002/14651858.CD008980.pub2. Review.

PMID:
23925867
6.

Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Ritchie C, Smailagic N, Noel-Storr AH, Takwoingi Y, Flicker L, Mason SE, McShane R.

Cochrane Database Syst Rev. 2014 Jun 10;(6):CD008782. doi: 10.1002/14651858.CD008782.pub4. Review.

PMID:
24913723
7.

[Atrial fibrillation and cognitive function].

Duron E, Hanon O.

Psychol Neuropsychiatr Vieil. 2010 Sep;8(3):209-14. doi: 10.1684/pnv.2010.0222. Review. French.

8.
9.

Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.

Li J, Liu J, Liu M, Zhang S, Hao Z, Zhang J, Zhang C.

Cochrane Database Syst Rev. 2015 Sep 8;(9):CD009938. doi: 10.1002/14651858.CD009938.pub2. Review.

PMID:
26346232
10.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

11.

Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care setting.

Harrison JK, Fearon P, Noel-Storr AH, McShane R, Stott DJ, Quinn TJ.

Cochrane Database Syst Rev. 2015 Mar 10;(3):CD010772. doi: 10.1002/14651858.CD010772.pub2. Review.

PMID:
25754745
12.
13.

Impact of metabolic syndrome on the risk of atrial fibrillation recurrence after catheter ablation: systematic review and meta-analysis.

Lin KJ, Cho SI, Tiwari N, Bergman M, Kizer JR, Palma EC, Taub CC.

J Interv Card Electrophysiol. 2014 Apr;39(3):211-23. doi: 10.1007/s10840-013-9863-x. Epub 2013 Dec 19. Review.

14.

Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.

Archer HA, Smailagic N, John C, Holmes RB, Takwoingi Y, Coulthard EJ, Cullum S.

Cochrane Database Syst Rev. 2015 Jun 23;(6):CD010896. doi: 10.1002/14651858.CD010896.pub2. Review.

PMID:
26102272
15.

Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review.

Lane DA, Raichand S, Moore D, Connock M, Fry-Smith A, Fitzmaurice DA; Steering Committee..

Health Technol Assess. 2013 Jul;17(30):1-188. doi: 10.3310/hta17300. Review.

16.

Association of smoking with the risk of incident atrial fibrillation: A meta-analysis of prospective studies.

Zhu W, Yuan P, Shen Y, Wan R, Hong K.

Int J Cardiol. 2016 Sep 1;218:259-66. doi: 10.1016/j.ijcard.2016.05.013. Epub 2016 May 14. Review.

PMID:
27236125
17.

Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation.

Salazar CA, del Aguila D, Cordova EG.

Cochrane Database Syst Rev. 2014 Mar 27;(3):CD009893. doi: 10.1002/14651858.CD009893.pub2. Review.

PMID:
24677203
18.

The association of antihypertensive medication use with risk of cognitive decline and dementia: a meta-analysis of longitudinal studies.

Chang-Quan H, Hui W, Chao-Min W, Zheng-Rong W, Jun-Wen G, Yong-Hong L, Yan-You L, Qing-Xiu L.

Int J Clin Pract. 2011 Dec;65(12):1295-305. doi: 10.1111/j.1742-1241.2011.02810.x. Review.

PMID:
22093537
19.

Bisphosphonates and atrial fibrillation: systematic review and meta-analysis.

Loke YK, Jeevanantham V, Singh S.

Drug Saf. 2009;32(3):219-28. doi: 10.2165/00002018-200932030-00004. Review.

PMID:
19338379
20.

The preventive effect of statin therapy on new-onset and recurrent atrial fibrillation in patients not undergoing invasive cardiac interventions: a systematic review and meta-analysis.

Bang CN, Greve AM, Abdulla J, Køber L, Gislason GH, Wachtell K.

Int J Cardiol. 2013 Aug 10;167(3):624-30. doi: 10.1016/j.ijcard.2012.08.056. Epub 2012 Sep 19. Review.

PMID:
22999824

Supplemental Content

Support Center